1. The metabolic syndrome(s)?

   • Andrew M. Tonkin

   Invited Commentary Pages: 165 - 166

2. Literature alert

   Announcement Pages: 168 - 170

3. Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy

   • Rajagopal V. Sekhar
   • Farook Jahoor
   • Ashok Balasubramanyam

   OriginalPaper Pages: 173 - 179

4. Antidiabetic actions of estrogen: Insight from human and genetic mouse models

   • Jean-Francois Louet
   • Cedric LeMay
   • Franck Mauvais-Jarvis

   OriginalPaper Pages: 180 - 185

5. The metabolic syndrome: A crossroad for genotype-phenotype associations in atherosclerosis

   • Dolores Corella
   • Jose M. Ordovas

   OriginalPaper Pages: 186 - 196

6. Use of genetic mouse models in the study of diabetic nephropathy

   • Terri J. Allen
   • Mark E. Cooper
   • Hui Y. Lan

   OriginalPaper Pages: 197 - 202

7. Liver-directed gene therapy for dyslipidemia and diabetes

   • Kazuhiro Oka
   • Lawrence Chan

   OriginalPaper Pages: 203 - 209

8. Imaging of coronary atherosclerosis using computed tomography: Current status and future directions

   • Stephan Achenbach
   • Werner G. Daniel

   OriginalPaper Pages: 213 - 218

9. Intravascular ultrasound assessment of atherosclerosis

   • Antoine Guédès
   • Jean-Claude Tardif

   OriginalPaper Pages: 219 - 224

10. Cardiovascular risk assessment in individual patients from carotid intimal-medial thickness measurements

    • Ward A. Riley

    OriginalPaper Pages: 225 - 231

11. Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque

    • Zahi A. Fayad
    • Marc Sirol
    • Valentin Fuster

    OriginalPaper Pages: 232 - 242

12. Inflammatory and oxidative markers in atherosclerosis: Relationship to outcome

    • Mehdi H. Shishehbor
    • Stanley L. Hazen

    OriginalPaper Pages: 243 - 250

13. Web alert

    Announcement Pages: 251 - 251